14 March 2023 LungLife AI, Inc. (the “Company” or “LungLife”) Appointment of Joint Broker LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for lung cancer, announces the appointment of Goodbody as the Company's Joint Broker with immediate effect. Investec Bank plc remains Nominated Adviser and Joint Broker to the Company. Click HERE for […]
13 March 2023 LungLife AI, Inc. (the “Company” or “LungLife”) Statement re. Silicon Valley Bank LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for lung cancer, is aware of media reports indicating the closure of Silicon Valley Bank (“SVB”). The Company does not hold any cash at SVB, nor does it have a […]
LungLife AI licensure/accreditation information posted here.